Cardiac OTULIN decreases, progranulin increases dynamically in experimental myocardial infarction and remodeling
Background
Acute myocardial infarction (MI), often followed by adverse cardiac remodeling, remains a leading cause of morbidity and mortality. Oxidative stress and inflammation are critical drivers of MI pathogenesis and subsequent remodeling, contributing to progressive heart dysfunction. Current therapeutic strategies often target these pathways but lack comprehensive approaches to monitor or modulate the dynamic changes in endogenous protective factors. Understanding novel biomarkers and therapeutic targets that reflect the evolving cardiac environment during and after MI is crucial for improving prognosis and treatment outcomes.
Study Design
Researchers investigated dynamic changes in OTULIN and progranulin (PRGN) levels in an experimental myocardial infarction (MI) model. MI was induced in animals using Isoproterenol (ISO), with groups representing key time points: ISO-6-h, ISO-24-h, ISO-3-day, and ISO-7-day, alongside control groups. The model's validity was confirmed by increased serum cardiac markers and histopathological changes. Oxidative stress and inflammation were assessed in heart tissue to confirm their emergence post-ISO administration.
Results
The experimental myocardial infarction (MI) model, induced by Isoproterenol (ISO), was successfully validated by elevated serum cardiac markers and distinct histopathological changes in heart tissue. Crucially, significant oxidative stress and inflammation were confirmed in the heart tissue following ISO administration. However, in the ISO-7-day group, a notable reduction in both oxidative stress and inflammation was observed, coinciding with the onset of cardiac remodeling. The study revealed a time-dependent decrease in cardiac OTULIN levels throughout the MI and remodeling phases. Conversely, cardiac PRGN levels exhibited a time-dependent increase. These dynamic, opposing changes suggest that both OTULIN and PRGN are actively involved in the complex processes of MI and subsequent cardiac remodeling.
In the
ISO-7-daygroup, a significant reduction in oxidative stress and inflammation was observed along with cardiac remodeling.
Key Findings
- Isoproterenol-induced MI model showed increased serum cardiac markers and histopathological changes.
- Oxidative stress and inflammation emerged in heart tissue after ISO administration.
- The
ISO-7-daygroup exhibited a significant reduction in oxidative stress and inflammation. - Cardiac OTULIN levels decreased in a time-dependent manner during MI and remodeling.
- Cardiac progranulin (PRGN) levels increased in a time-dependent manner during MI and remodeling.
Why It Matters
This study highlights OTULIN and progranulin (PRGN) as potential novel biomarkers for myocardial infarction (MI) prognosis and progression, offering new avenues for monitoring cardiac health post-event. For clinicians and researchers, these findings suggest that modulating OTULIN or PRGN pathways could represent future therapeutic strategies to mitigate adverse cardiac remodeling. While this is a preclinical animal study, the identification of endogenous factors with dynamic changes during MI provides a foundation for developing targeted interventions. Further research is needed to translate these findings into human protocols, but it opens the door for exploring OTULIN and PRGN as molecular targets in drug discovery for MI and heart failure.
myocardial-infarction
cardiac-remodeling
otulin
progranulin
oxidative-stress
inflammation